UB Paderborn / Katalog / Suche / in CDI

Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis

IEEE transactions on medical imaging, 2022-04, Vol.41 (4), p.757-770

2022

Link zum Volltext
Volltext

Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion

Journal of clinical oncology, 2022-04, Vol.40 (11), p.1231-1258

2022

Link zum Volltext

Verfügbarkeit prüfen

Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies

The Journal of molecular diagnostics : JMD, 2016-07, Vol.18 (4), p.507-515

2016

Link zum Volltext

Verfügbarkeit prüfen

Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer

Archives of pathology & laboratory medicine (1976), 2017-06, Vol.141 (6), p.751-758

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Journal of thoracic oncology, 2013-07, Vol.8 (7), p.823-859

2013

Link zum Volltext

Verfügbarkeit prüfen

Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing

The Journal of molecular diagnostics : JMD, 2017, Vol.19 (1), p.84-91

2017

Link zum Volltext

Verfügbarkeit prüfen

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

The Journal of molecular diagnostics : JMD, 2017-01, Vol.19 (1), p.4-23

2017

Link zum Volltext

Verfügbarkeit prüfen

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges

Neuro-oncology (Charlottesville, Va.), 2019-02, Vol.21 (2), p.167-178

2019

Link zum Volltext

Verfügbarkeit prüfen

Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer

Clinical cancer research, 2020-06, Vol.26 (11), p.2565-2572

2020

Link zum Volltext

Verfügbarkeit prüfen

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Archives of pathology & laboratory medicine (1976), 2013-06, Vol.137 (6), p.828-860

2013

Link zum Volltext

Verfügbarkeit prüfen

Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions

Journal of thoracic oncology, 2013-02, Vol.8 (2), p.179-184

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology

Journal of clinical oncology, 2017-03, Vol.35 (9), p.929-933

2017

Link zum Volltext

Verfügbarkeit prüfen

BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers

Nucleic acids research, 2015-02, Vol.43 (3), p.e19

2015

Link zum Volltext

Verfügbarkeit prüfen

Worldwide Frequency of Commonly Detected EGFR Mutations

Archives of pathology & laboratory medicine (1976), 2018-02, Vol.142 (2), p.163-167

2018

Link zum Volltext

Verfügbarkeit prüfen

Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

Cancer cell, 2010-01, Vol.17 (1), p.77-88

2010

Link zum Volltext

Verfügbarkeit prüfen

Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants

Modern pathology, 2021-02, Vol.34 (2), p.457-468

2021

Link zum Volltext

Verfügbarkeit prüfen

Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays

Archives of pathology & laboratory medicine (1976), 2019-04, Vol.143 (4), p.463-471

2019

Link zum Volltext

Verfügbarkeit prüfen

Sarcomatoid Yolk Sac Tumor Harbors Somatic Mutations That Are Otherwise Rare in Testicular Germ Cell Tumors

The American journal of surgical pathology, 2022-05, Vol.46 (5), p.701

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer

Journal of clinical oncology, 2019-10, Vol.37 (30), p.2786-2794

2019

Link zum Volltext

Verfügbarkeit prüfen

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

Blood, 2015-02, Vol.125 (9), p.1367-1376

2015

Link zum Volltext

Verfügbarkeit prüfen

SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma

Modern pathology, 2018-09, Vol.31 (9), p.1442-1456

2018

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Pathomic Fusion: An Integrated Framework for Fusing Histopathology and Genomic Features for Cancer Diagnosis and Prognosis

Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion

Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic Malignancies

Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges

Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

Natural History and Molecular Characteristics of Lung Cancers Harboring EGFR Exon 20 Insertions

Clinical and Technical Aspects of Genomic Diagnostics for Precision Oncology

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology

BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers

Worldwide Frequency of Commonly Detected EGFR Mutations

Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants

Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays

Sarcomatoid Yolk Sac Tumor Harbors Somatic Mutations That Are Otherwise Rare in Testicular Germ Cell Tumors

Phase II Study of Avelumab in Patients With Mismatch Repair Deficient and Mismatch Repair Proficient Recurrent/Persistent Endometrial Cancer

Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

SMARCA4-deficient undifferentiated uterine sarcoma (malignant rhabdoid tumor of the uterus): a clinicopathologic entity distinct from undifferentiated carcinoma

Suchergebnisse filtern